Fort Worth, TX - (NewMediaWire) - March 7, 2019 - Water Now, Inc., (OTC: WTNW), a leader in water purification solutions, today announced it has retained Porter, LeVay & Rose, Inc. (“PLR”) as its investor relations consultant. Discussing the engagement, David King, Chief Executive Officer, commented: “Our mission continues to be to develop and refine a mobile water purification system that is capable of converting pond, river and salt water into clean drinking portable water. Porter, LeVay & Rose understands this mission and is as enthusiastic as us to help solve this global problem. I’m very excited to have PLR as our advisor.”Michael Porter, President of Porter, LeVay & Rose, commented: “Water is a basic human right yet 844 million people in the world don’t have access to clean water. But, Water Now has come up with innovative and cost-effective solutions to solve this problem. We are delighted to be working with Water Now, Inc. The company’s amazing technology will prove to be game changing in the water purification space and assist in providing safe drinking water from virtually any water source available.”Forward Looking StatementsStatements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements Water Now, Inc. to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Water Now, Inc. assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission ("SEC"). There may be other factors not mentioned above or included in the Water Now's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. Water Now, Inc. assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.Jaclyn Osborn 817-900-9184 josborn@waternowinc.com www.waternowinc.com
In LOPEC, the European Event for Printed Electronics That Successfully Brings Together Technologies and BusinessMIGDAL HA'EMEK, ISRAEL - (NewMediaWire) - March 07, 2019 - PV Nano Cell, Ltd. (OTCQB: PVNNF) ("PV Nano Cell" or the "Company"), an innovative producer of conductive digital inks and provider of inkjet-based digital printing solutions, today announced it will be exhibiting in the LOPEC exhibition, the leading event for Printed Electronics in Europe, March 20th to 21st in Munich Germany (https://www.lopec.com/). Visit Hall B0 Booth 101.PV Nano Cell will launch in the exhibition its complete solution offering for the printed electronics, mass-production applications. The company will also show its latest ink developments, sample applications focused on mass production and the integrated printer for design, prototyping and R&D – DemonJet™.PV Nano Cell has designed & implemented a solution approach that allows customers to fully realize the potential of inkjet-based electronics printing for mass production applications. The first successful implementation of such a solution is the result of a cooperation with Dip-Tech, a FERRO company. Ferro & Dip-Tech are selling inks & printers for the purpose of printing on wide glass applications, architecture & automotive with hundreds of printers installed. Dip-Tech has recently introduced printers and ink for conductive printing based on PV Nano Cell’s Sicrys™, silver-based ink. The first mass production application is in automotive, printing electrical patterns on windshields.This successful cooperation for mass production application demonstrates PV Nano Cell’s approach to offer a complete solution: ink, printer and printing process.PV Nano Cell now offers customers industrial-grade proven family of inks and mass-production printers. In addition PV Nano Cell develops for the customer the printing process, The Process relates to the recipe, fine details and know-how of using the printer and ink to obtain the desired results for mass-production 24/7 printing. Such know-how may include: ink properties' tweaking, printer parameters setup, printer modifications, tailored sintering instructions and more. Finally, for mass-production customers, requiring above 400 kg of ink annually, PV Nano Cell offers subsidized printers.We encourage you to approach us with your needs and requirements in digital printing mass production electronics applications.PV Nano Cell, Ltd.PV Nano Cell has developed innovative conductive inks for use in printed electronics (PE) and solar photovoltaics (PV) applications. PV Nano Cell's Sicrys™ ink family is a single-crystal, nano metric metal conductive ink delivering enhanced performance. Sicrys™ is available in silver and copper-based form, both compatible with many inkjet print heads and mass production enablers (high throughput printing, high quality and competitive pricing). Sicrys™ conductive inks are used all over the world in a range of inkjet printing applications, including photovoltaics, printed circuit boards, antennas, sensors, touchscreens and other applications. For more information, please visit www.PVNanoCell.com.Forward-Looking StatementsThis press release contains forward–looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward–looking statements." All information set forth in this news release, except historical and factual information, represents forward–looking statements. This includes all statements about the Company's plans, beliefs, estimates and expectations. These statements are based on current estimates and projections, which involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward–looking statements. These risks and uncertainties include issues related to: rapidly changing technology and evolving standards in the industries in which the Company operates; the ability to obtain ...
Atlanta, GA - (NewMediaWire) - March 07, 2019 - Viratech Corp. is pleased to announce the filing of financial statements as of September 30, 2018. This was due to the company, aside from entering the marketing phase of its products, had made two acquisitions during the first half of 2018, both of which will be discussed further in news releases. The company had to bring all accounting records to full GAAP compliancy and gained knowledge of these deficiencies in late 2018 when the holiday season had commenced. In the future, the company does not expect for this to be an issue as the company plans to timely file its annual report and maintain full compliance with such deadlines. Cambridge Golf, a wholly-owned subsidiary of Viratech Corp. (OTC PINK: VIRA), continues to target the rapidly growing multi-billion-dollar US market for golf, nutrition, and wellness products with the acquisition of Medori, LLC (www.medoricbd.com), headquartered in Atlanta, GA. Medori produces and markets the finest CBD products in the world, by using the finest organic hemp grown to the strictest standards to ensure the highest quality. In addition, Medori is dedicated to the research and development of premium hemp extracts containing a wide array of cannabinoids and organic hemp derivatives. Medori CBD products are available uninhibitedly in all 50 states as they are produced using federally legal CBD. Products can be purchased immediately on its web site, www.medoricbd.com, for domestic and select international delivery, as well as plans to be in select retailers.With Cambridge focusing on a generational game such as golf where the core demographic continues to age and the main injuries sustained during play tend to be of the muscular and joint related nature, the emerging CBD market with the benefits of such products allow golfers to potentially extend their playing years by adding CBD to their daily golf ritual. With the addition of Medori, Cambridge Golf continues to position itself to bring innovation to the golfing market with creative performance, nutrition, and health/wellness products.“The addition of Medori CBD is in line with our strategy of organic and inorganic (acquisitions) growth to ensure long term shareholder and Company value,” commented Craig Forney, President and Chief Executive Officer. He added, “We are pleased to add Dr. Anthony Didato, Dr. Brian Pugh and their team to Cambridge, Medori will continue to serve its existing markets with current and future products. We have plans to leverage their market leading product formulations and packaging/branding acumen to create industry leading golf focused CBD products under our Gimme Brand. Details of this acquisition caused a small delay in Cambridge Golf financial reporting filings as we needed to ensure full accounting compliance and completeness.”“Cambridge Golf is a platform to accelerate innovation for the golfing market. We are excited to join their team of companies and add innovative and beneficial CBD products to expand their market coverage,” stated Dr. Anthony Didato, Managing Partner Medori CBD. He added, “CBD oil can help to regulate sleep, mood, pain and inflammation, allowing you to maintain an internal balance despite the ups and downs of life - and your golf game!”About Cambridge Golf:Cambridge Golf is publicly traded holding company that designs and manufactures innovative sporting goods, clothing, supplements and accessories to the sports, nutrition and golf markets. The Company plans on continuing to extend and deepen its product lines to include other progressive market segments through acquisitions and organic growth of existing product lines. Cambridge Golf is publicly traded on the OTC market under the symbol (VIRA). www.cambridgegolfing.comForward-Looking Statements:This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These ...
Pueblo, CO - (NewMediaWire) - March 07, 2019 - CannaGrow Holdings, Inc. (OTC PINK: CGRW), A Liaison and Consultant providing turnkey solutions to licensed growers -- CannaGrow Holdings, Inc. announces the Huerfano County Building Department has issued a Temporary Certificate of Occupancy, as of March 6, 2019, based upon the completion of construction of the 1,600 sq. ft. steel building to be used exclusively for the Drying, Curing, and Packaging of the Cannabis being harvested at the Colorado Buffalo Ranch Facility. Delmar Janovec, CEO, stated, “Like everything else that has been built at the Colorado Buffalo Ranch Facility, the new building is State of the Art. The facility is 100% Climate Controlled, designed and built exclusively for Drying, Curing, and Packaging. The different computerized systems will work concurrently to eliminate humidity fluctuations caused by the extreme variance of temperature ranges within each 24-hour period in Southern Colorado. A special heavy-duty foam insulation was used throughout the entire building to stabilize indoor temperatures within a few degrees. Humidifier and Dehumidifier Systems were installed along with cutting edge Sensory Technology. Janovec went on to say, "Our objective was to create an ideal hermetic and sanitary environment to eliminate any potential mold, mildew, or fungus threats that can occur during the Drying, Curing, and Packaging Process, and that is exactly what has been accomplished. This 1600 sq. ft. facility will adequately handle the winter production cycles currently taking place in the six (6) 2,880 sq. ft. Climate Controlled IGC Ranger Series 2000 Greenhouses in addition to the Summer/Fall harvest that have already proven to be in excess of one thousand (1,000) pounds of product. With this building project checked off of the list we can start to look toward the future expansion into Phases III, IV, and V of our Master Plan."Rod Clawson, “Managing Director of Category One Botanicals, the Licensed Grower at the Colorado Buffalo Ranch Facility added, I am continually amazed at how far C1B has come since receiving the Colorado State Recreational Growers License back in April of 2016. With a committed developer like NuGro Industries and a Property Manager like CannaGrow Holdings, I can see Category One Botanicals taking a lead role in the Cannabis Industry in the State of Colorado.”CannaGrow Holdings, Inc., the Liaison and Representative for NuGro Industries, will continue in its capacity of providing oversight as the Property Manager, working with the State/County Agencies and Category One Botanicals, LLC, the Licensed Grower for the facilities. The completion of this project will now provide the company the basis to begin generating revenues from Licensed Growers subleasing the Turnkey facilities being built to the specifications of Consultants, Dr. John P. Janovec, and Jason Wells.About CannaGrow Holdings, Inc.:CannaGrow Holdings, Inc. has entered the Medical/Recreational Cannabis Industry as a Lessor, Liaison, and Consultant to licensed Growers providing them with turnkey Growing Facilities in the State of Colorado. The Company intends to expand this business model within this industry as business opportunities evolve whereby providing for the highest return to its shareholders.CannaGrow Holdings, Inc. does not and will not, until Federal law allows, grow, harvest, distribute, or sell marijuana or any substance that violates the laws of the United States of America.CannaGrow Holdings, Inc. encourages the public to read the above information in conjunction with its year-end statement for December 31, 2017, and the quarterly statements filed in calendar year 2018, at: www.otcmarkets.com. The information contained in this press release may include forward-looking statements. Forward-looking statements usually contain the words "may," "could," "possibly," "feel," "estimate," "anticipate," "believe," "expect," or similar expressions that involve risks and uncertainties. These risks and uncertainties include the Company's uncertain profitability, need for ...
Houston, TX, March 06, 2019 (NewMediaWire) -- AngioSoma, Inc. (OTC: SOAN) announced today the Company is excited about recent news of accomplishments of Diabetes Relief LLC, whose patented process and procedures treat the root cause of diabetes, instead of just the symptoms, resulting in patient improvement greater than with conventional treatment. Diabetes Relief Adds Key Milestones for 2019Diabetes Relief is meeting its goals for new licensed facilities by adding a third Houston captive facility and licensing new centers in Austin, California, and Florida. “Diabetes Relief is poised to improve the lives of millions of diabetics all over the world,” said Scott Hepford, Manager of Diabetes Relief LLC. Diabetes Relief’s Georgia Facility Exceeds ExpectationsDiabetes Relief reports that its licensee in Southeast Georgia has exceeded all hopes for profitability and patient improvements and is looking to expand to Atlanta. “This is what we have envisioned for the Company, and it is exciting to see it happen,” stated Brian Loveridge, MD, Regional Medical Director for Diabetes Relief LLC. “As Diabetes Relief continues to see improvement where conventional treatment has failed, the demand for its patented product are booming,” Dr. Loveridge added. Kerrie Dawson, CEO of DR’s first Georgia expansion, reported that “DR is worth the investment in so many ways for a practice, and we have saved one lady’s leg from amputation!” Diabetes Relief Licensed Facilities Grow to 11With the addition of licensed facilities in Jacksonville, Florida, and Thousand Oaks, California, Diabetes Relief’s patented treatment is now offered in 11 facilities and the company is working hard to keep up with the demand for licenses. “We are making plans for a comprehensive peer-reviewed, double-blind study of our amazing process that is changing so many lives once believed hopeless,” said Dr. Stanley Lewis, the Company’s Chief Medical Officer, “while handling the many requests for licenses.” ABOUT DIABETES RELIEF LLC Diabetes Relief LLC is a privately-held company that began in 2015 with one facility in Houston. Diabetes Relief’s patented process helps patients with all metabolic disorders, dominated by diabetes. Patients report improvements with Diabetes Relief's physiologic insulin administration that they have found nowhere else and with no other treatment or prescription drugs. Its rapidly growing licensees now provide services and products in 5 states and 3 other countries that promote healthier living and an improved quality of life for those living with diabetes and other metabolic dysfunction. Information and patient testimonials are available at www.diabetesrelief.com.ABOUT ANGIOSOMA, INC.AngioSoma, Inc. (https:// angiosoma.com), a Nevada corporation based in Houston, Texas, is dedicated to improving the mental and physical wellbeing of men and women. To accomplish that purpose, we are launching a line of supplements under our Somaceuticals™ common identity. Our supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.NOTICE REGARDING FORWARD LOOKING STATEMENTSSafe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate,” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.CONTACT AngioSoma, Inc. Alex Blankenship investors@AngioSoma.com (832) 781-8521
